Charles Schwab’s Apollo Endosurgery, Inc. APEN Stock Holding History

Charles Schwab’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,931	Closed	-$138K	–	3753
2023 Q1	$138K	Sell	13,931 -3,267	-19%	-$32.4K	﹤0.01%	3211
2022 Q4	$171K	Hold	17,198	–	–	﹤0.01%	3203
2022 Q3	$95K	Hold	17,198	–	–	﹤0.01%	3228
2022 Q2	$63K	Hold	17,198	–	–	﹤0.01%	3359
2022 Q1	$105K	Buy	+17,198	New	+$105K	﹤0.01%	3407

Charles Schwab's APEN Position: Q2 2023 in Review

Charles Schwab sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 13,931 shares — an estimated $138K sold.

Charles Schwab first reported a position in APEN in Q1 2022 and held it in 5 quarters. The position peaked at $171K in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Charles Schwab reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Charles Schwab sold 13,931 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $138K.
Charles Schwab first reported a position in Apollo Endosurgery, Inc. in Q1 2022 and held it in 5 quarters.
Charles Schwab's Apollo Endosurgery, Inc. position peaked at $171K in Q4 2022.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.